Skip to main content
OpenTrials
Completed

NCT Number: NCT04264325

Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability Study

Malignant pleural effusions cause breathlessness and impairs quality of life. Thoracocentesis is frequently used to relieve breathlessness.

The severity of breathlessness correlates poorly with the size of the effusion. Symptom reduction from fluid drainage varies between patients. No predictors exist to identify which patients benefits more of pleural effusion. One study suggests that a inverted hemidiaphramatic (inverted shape) is associated with a greater dyspnea improvement. Others parameters of diaphragmatic motion have not been studied till now.

This study aims to evaluate the feasability of diaphragmatic ultrasound evaluation (shape by B-mode, quiet, deep inspiratory motion and sniff diaphragm motion by TM-mode) before and after pleural drainage.

Primary end point aims to evaluate the feasability of deep breath inspiratory excursion in ipsilateral side of thoracocentesis by anterior subcostal approach in the mid-clavicular line in the right in patients with malignant pleural effusions. The liver or spleen was identified as a window for each hemidiaphragm.

Secondary end points aim to evaluate

* the feasability of quiet breath inspiratory motion , * the feasability of sniff diaphragm motion * the feasability of deep breath inspiratory motion by posterior method * the comparaison of feasibility with different types of breathing and or anterior or posterior approach for ultrasound * the feasability of the shape by B-mode. * the correlation between the change of the shape of ipsilateral diaphragm and the evolution of dyspnea, before and after thoracocentesis. * the correlation between the volume of pleural effusion evacuated and the evolution of dyspnea, before and after thoracocentesis. * the comparaison of the changing of dyspnea in patients with noticed paradoxal movement of diaphragm before thoracocentesis and patients with persistent paradoxal/or non persistant paradoxal movement of ipsilateral hémidiaphragm. * the correlation between the feasability of diaphragmatic ultrasound motion measurments evaluation and the body mass index. * the comparaison between the different diaphragmatic ultrsound times for anterior or posterior approach.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age> 18 years old
  • Male or female patient
  • Patient with known lung cancer, regardless of histology or suspected of having unknown lung cancer or relapse / progression of lung cancer
  • Presenting a pleural effusion with clinical necessity of evacuating pleural puncture
  • Subject who expressed his non opposition to the research

Exclusion criteria

  • Patient's refusal to participate in the study
  • History of pleurodesis whatever the indication (pneumothorax or recurrent pleural effusion) or the technique used
  • Permanent chest drain
  • inability to provide informed information to the subject (subject in an emergency, difficulty understanding the subject, etc.)
  • Subject under judicial protection
  • Subject under guardianship or curatorship
  • Pregnant or lactating woman

Treatment and study plan

diaphragmatic ultrasound measure

Other

patients with lung neoplasms and malignant pleural effusions who need a diagnostic or therapeutic thoracocentesis

Primary outcomes

  1. Evaluate the feasibility of measuring the diaphragmatic amplitude in wide breathing (RA) on the side homolateral to the pleural puncture

    Time frame: one day

    Rate of patients with a feasible measure of diaphragmatic amplitude in wide breathing (RA), on the side homolateral to the pleural puncture, by the anterior route before and after pleural puncture.

Secondary outcomes

  1. Feasability of quiet breath inspiratory motion

    Time frame: one day

    Rate of patients with a feasible measure of diaphragmatic amplitude in spontaneous breathing (RS), on the side homolateral to the pleural puncture, by the anterior route before and after pleural puncture.

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions

Acronym: ADD-Echo

Important dates

Study start
2020
Primary completion
2020
Study completion
2023
First posted
Feb 11, 2020
Registry last updated
May 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.